World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
50
Citations
20725
World Ranking
4180
National Ranking
45

Weijin Huang publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Weijin Huang sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 272 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Weijin Huang D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Weijin Huang sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 50 D-Index — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Weijin Huang is affiliated with the National Institutes for Food and Drug Control in China and has contributed extensively to research in the field of medicine, particularly focusing on infectious diseases. The scientist's work primarily addresses aspects of SARS-CoV-2 and COVID-19, covering a wide range of topics related to viral infections, immunology, and epidemiology.

Weijin Huang's scholarly output spans several important subfields including infectious diseases, epidemiology, molecular biology, immunology, and animal science and zoology. These areas collectively frame the scope of research activities and investigations.

The main research topics explored by this scientist include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • Animal Virus Infections Studies
  • Vaccines and immunoinformatics approaches
  • Viral gastroenteritis research and epidemiology
  • Viral Infections and Outbreaks Research

Frequent collaborators in research projects include Youchun Wang, Jianhui Nie, Shuo Liu, Jiajing Wu, and Qianqian Li. Collaborative work with these coauthors reflects a consistent engagement with a close network of scientists in related fields.

Weijin Huang's publications have appeared regularly in several scientific venues. Most notable among them are:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Emerging Microbes & Infections
  • Signal Transduction and Targeted Therapy
  • Journal of Medical Virology
  • Viruses

Significant recent papers coauthored include:

  • "Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies," 2021, published in Nature
  • "The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity," 2020, published in Cell
  • "A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2," 2020, published in Nature
  • "BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection," 2022, published in Nature
  • "Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial," 2020, published in The Lancet Infectious Diseases

Best Publications

  • Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

    Unknown

  • A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2.

    Rui Shi;Chao Shan;Xiaomin Duan;Zhihai Chen

  • The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity.

    Qianqian Li;Jiajing Wu;Jianhui Nie;Li Zhang

  • BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

    Unknown

  • Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.

    Shengli Xia;Yuntao Zhang;Yanxia Wang;Hui Wang

  • A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity.

    Jingyun Yang;Wei Wang;Zimin Chen;Shuaiyao Lu

  • Circular RNA vaccines against SARS-CoV-2 and emerging variants

    Unknown

  • Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2.

    Jianhui Nie;Qianqian Li;Jiajing Wu;Chenyan Zhao

  • A Thermostable mRNA Vaccine against COVID-19.

    Na Na Zhang;Xiao Feng Li;Yong Qiang Deng;Hui Zhao

  • A Mouse Model of SARS-CoV-2 Infection and Pathogenesis.

    Shi Hui Sun;Qi Chen;Hong Jing Gu;Guan Yang

  • Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development.

    Miao-Miao Zhao;Wei-Li Yang;Fang-Yuan Yang;Li Zhang

  • Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay

    Jianhui Nie;Qianqian Li;Jiajing Wu;Chenyan Zhao

  • Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody

    Zhe Lv;Yong Qiang Deng;Qing Ye;Lei Cao

  • The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron

    Unknown

  • SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape.

    Qianqian Li;Jianhui Nie;Jiajing Wu;Li Zhang

  • Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy.

    Shuo Du;Yunlong Cao;Qinyu Zhu;Pin Yu

  • Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

    Unknown

  • High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients.

    Yuxin Chen;Xin Tong;Jian Wang;Weijin Huang

  • Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants

    Unknown

  • Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial.

    ShengLi Xia;YunTao Zhang;YanXia Wang;Hui Wang

  • Detection and assessment of infectivity of hepatitis E virus in urine.

    Yansheng Geng;Chenyan Zhao;Weijin Huang;Tim J. Harrison

  • S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates.

    Joshua G Liang;Danmei Su;Tian-Zhang Song;Yilan Zeng

  • Current status on the development of pseudoviruses for enveloped viruses

    Qianqian Li;Qiang Liu;Weijin Huang;Xuguang Li

  • Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines.

    Yunlong Cao;Ayijiang Yisimayi;Yali Bai;Yali Bai;Weijin Huang

  • Persistent hepatitis e virus genotype 4 infection in a child with acute lymphoblastic leukemia.

    Yansheng Geng;Hongxin Zhang;Weijin Huang;Tim J Harrison

  • Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2.

    Qi Zhang;Bin Ju;Jiwan Ge;Jasper Fuk-Woo Chan;Jasper Fuk-Woo Chan

Frequent Co-Authors

Youchun Wang
Youchun Wang Chinese Academy of Sciences
George F. Gao
George F. Gao Chinese Center For Disease Control and Prevention
Cheng-Feng Qin
Cheng-Feng Qin Chinese Academy of Sciences
Zihe Rao
Zihe Rao Tsinghua University
Yuhai Bi
Yuhai Bi Chinese Academy of Sciences
Yong-Qiang Deng
Yong-Qiang Deng Academy of Military Medical Sciences
Jinghua Yan
Jinghua Yan Chinese Academy of Sciences
Jasper F. W. Chan
Jasper F. W. Chan University of Hong Kong
Jianxun Qi
Jianxun Qi Chinese Academy of Sciences
Kwok-Yung Yuen
Kwok-Yung Yuen University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to diverse healthcare and research roles. Many students complement their studies by exploring related online degrees such as psychiatric mental health nursing, which offers specialized knowledge in patient care. For those interested in advanced nursing roles, considering top top psychiatric mental health nurse practitioner programs online is a practical step to enhance clinical expertise and career prospects.

Cost is often a key concern when choosing further education. Fortunately, several affordable options exist, and exploring the cheapest online pmhnp programs can help students balance quality and budget effectively.

Career advancement also depends on understanding compensation trends. Data on dnp salary by specialty provides valuable insight for those considering Doctor of Nursing Practice paths tied to immunology-related disciplines. This knowledge aids informed decision-making regarding specialization and location.

Additionally, nursing professionals looking to shift focus can benefit from bridge programs. For example, an fnp to acute care np bridge program offers a streamlined way to gain acute care expertise, expanding career opportunities in immunology-driven healthcare settings.

Best Scientists Citing Weijin Huang

Trending Scientists

Recently Published Articles